File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pharmaceutical care for elderly patients shared between community pharmacists and general practitioners: A randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128]

TitlePharmaceutical care for elderly patients shared between community pharmacists and general practitioners: A randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128]
Authors
KeywordsAged
Article
Clinical Trial
Community Care
Controlled Clinical Trial
Controlled Study
Cost Effectiveness Analysis
Elderly Care
General Practitioner
Government
Health Service
Home Care
Human
Medical Education
Medical Information
Monitoring
Patient Care
Patient Compliance
Pharmaceutical Care
Pharmacist
Quality Of Life
Randomized Controlled Trial
Side Effect
Society
United Kingdom
Issue Date2004
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmchealthservres/
Citation
Bmc Health Services Research, 2004, v. 4, p. 1-11 How to Cite?
AbstractBackground: This trial aims to investigate the effectiveness and cost implications of 'pharmaceutical care' provided by community pharmacists to elderly patients in the community. As the UK government has proposed that by 2004 pharmaceutical care services should extend nationwide, this provides an opportunity to evaluate the effect of pharmaceutical care for the elderly. Design: The trial design is a randomised multiple interrupted time series. We aim to recruit 700 patients from about 20 general practices, each associated with about three community pharmacies, from each of the five Primary Care Trusts in North and East Yorkshire. We shall randomise the five resulting groups of practices, pharmacies and patients to begin pharmaceutical care in five successive phases. All five will act as controls until they receive the intervention in a random sequence. Until they receive training community pharmacists will provide their usual dispensing services and so act as controls. The community pharmacists and general practitioners will receive training in pharmaceutical care for the elderly. Once trained, community pharmacists will meet recruited patients, either in their pharmacies (in a consultation room or dispensary to preserve confidentiality) or at home. They will identify drug-related issues/problems, and design a pharmaceutical care plan in conjunction with both the GP and the patient. They will implement, monitor, and update this plan monthly. The primary outcome measure is the 'Medication Appropriateness Index'. Secondary measures include adverse events, quality of life, and patient knowledge and compliance. We shall also investigate the cost of pharmaceutical care to the NHS, to patients and to society as a whole.
Persistent Identifierhttp://hdl.handle.net/10722/132897
ISSN
2015 Impact Factor: 1.606
2015 SCImago Journal Rankings: 1.128
References

 

DC FieldValueLanguage
dc.contributor.authorWong, Ien_HK
dc.contributor.authorCampion, Pen_HK
dc.contributor.authorCoulton, Sen_HK
dc.contributor.authorCross, Ben_HK
dc.contributor.authorEdmondson, Hen_HK
dc.contributor.authorFarrin, Aen_HK
dc.contributor.authorHill, Gen_HK
dc.contributor.authorHilton, Aen_HK
dc.contributor.authorPhilips, Zen_HK
dc.contributor.authorRichmond, Sen_HK
dc.contributor.authorRussell, Ien_HK
dc.date.accessioned2011-04-04T07:57:52Z-
dc.date.available2011-04-04T07:57:52Z-
dc.date.issued2004en_HK
dc.identifier.citationBmc Health Services Research, 2004, v. 4, p. 1-11en_HK
dc.identifier.issn1472-6963en_HK
dc.identifier.urihttp://hdl.handle.net/10722/132897-
dc.description.abstractBackground: This trial aims to investigate the effectiveness and cost implications of 'pharmaceutical care' provided by community pharmacists to elderly patients in the community. As the UK government has proposed that by 2004 pharmaceutical care services should extend nationwide, this provides an opportunity to evaluate the effect of pharmaceutical care for the elderly. Design: The trial design is a randomised multiple interrupted time series. We aim to recruit 700 patients from about 20 general practices, each associated with about three community pharmacies, from each of the five Primary Care Trusts in North and East Yorkshire. We shall randomise the five resulting groups of practices, pharmacies and patients to begin pharmaceutical care in five successive phases. All five will act as controls until they receive the intervention in a random sequence. Until they receive training community pharmacists will provide their usual dispensing services and so act as controls. The community pharmacists and general practitioners will receive training in pharmaceutical care for the elderly. Once trained, community pharmacists will meet recruited patients, either in their pharmacies (in a consultation room or dispensary to preserve confidentiality) or at home. They will identify drug-related issues/problems, and design a pharmaceutical care plan in conjunction with both the GP and the patient. They will implement, monitor, and update this plan monthly. The primary outcome measure is the 'Medication Appropriateness Index'. Secondary measures include adverse events, quality of life, and patient knowledge and compliance. We shall also investigate the cost of pharmaceutical care to the NHS, to patients and to society as a whole.en_HK
dc.languageengen_US
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmchealthservres/en_HK
dc.relation.ispartofBMC Health Services Researchen_HK
dc.subjectAgeden_US
dc.subjectArticleen_US
dc.subjectClinical Trialen_US
dc.subjectCommunity Careen_US
dc.subjectControlled Clinical Trialen_US
dc.subjectControlled Studyen_US
dc.subjectCost Effectiveness Analysisen_US
dc.subjectElderly Careen_US
dc.subjectGeneral Practitioneren_US
dc.subjectGovernmenten_US
dc.subjectHealth Serviceen_US
dc.subjectHome Careen_US
dc.subjectHumanen_US
dc.subjectMedical Educationen_US
dc.subjectMedical Informationen_US
dc.subjectMonitoringen_US
dc.subjectPatient Careen_US
dc.subjectPatient Complianceen_US
dc.subjectPharmaceutical Careen_US
dc.subjectPharmacisten_US
dc.subjectQuality Of Lifeen_US
dc.subjectRandomized Controlled Trialen_US
dc.subjectSide Effecten_US
dc.subjectSocietyen_US
dc.subjectUnited Kingdomen_US
dc.titlePharmaceutical care for elderly patients shared between community pharmacists and general practitioners: A randomised evaluation. RESPECT (Randomised Evaluation of Shared Prescribing for Elderly people in the Community over Time) [ISRCTN16932128]en_HK
dc.typeArticleen_HK
dc.identifier.emailWong, I: wongick@hku.hken_HK
dc.identifier.authorityWong, I=rp01480en_HK
dc.description.naturepublished_or_final_versionen_US
dc.identifier.scopuseid_2-s2.0-4544380522en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-4544380522&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume4en_HK
dc.identifier.spage1en_HK
dc.identifier.epage11en_HK
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridWong, I=7102513915en_HK
dc.identifier.scopusauthoridCampion, P=7006820227en_HK
dc.identifier.scopusauthoridCoulton, S=12774928900en_HK
dc.identifier.scopusauthoridCross, B=15044089300en_HK
dc.identifier.scopusauthoridEdmondson, H=17340277200en_HK
dc.identifier.scopusauthoridFarrin, A=6603339262en_HK
dc.identifier.scopusauthoridHill, G=7401964095en_HK
dc.identifier.scopusauthoridHilton, A=7103389186en_HK
dc.identifier.scopusauthoridPhilips, Z=6603428430en_HK
dc.identifier.scopusauthoridRichmond, S=24382167500en_HK
dc.identifier.scopusauthoridRussell, I=7201981270en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats